Vimarsana
Biggest News Aggregation in the World

Page 6 - Cbtx Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cbtx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cbtx Inc Today - Breaking & Trending Today

Michael A. Havard Acquires 10,477 Shares of CBTX, Inc. (NASDAQ:CBTX) Stock - Vimarsana News

Michael A. Havard Acquires 10,477 Shares of CBTX, Inc. (NASDAQ:CBTX) Stock

CBTX, Inc. (NASDAQ:CBTX – Get Rating) Director Michael A. Havard bought 10,477 shares of the business’s stock in a transaction that occurred on Friday, June 3rd. The stock was acquired at an average cost of $28.60 per share, with a total value of $299,642.20. Following the completion of the acquisition, the director now owns 58,811 […]

Merger Arbitrage Mondays: Broadcom To Acquire VMware For $69 Billion (NYSE:VMW) - Vimarsana News

Merger Arbitrage Mondays: Broadcom To Acquire VMware For $69 Billion (NYSE:VMW)

One of the largest tech deals in M&A history was announced last week. Chipmaker Broadcom entered into an agreement to acquire VMware for $69 billion in a cash or stock deal.

Allegiance Bancshares, Inc. and CBTX, Inc. Shareholders Approve Merger - Vimarsana News

Allegiance Bancshares, Inc. and CBTX, Inc. Shareholders Approve Merger

25.05.2022 - HOUSTON, May 24, 2022 (GLOBE NEWSWIRE) - Allegiance Bancshares, Inc. (NASDAQ: ABTX) (“Allegiance”), the holding company of Allegiance Bank, and CBTX, Inc. (NASDAQ: CBTX) ('CBTX'), the holding company of CommunityBank of Texas, N.A., announced ... Seite 1

CBTX (NASDAQ:CBTX) Rating Increased to Strong-Buy at Zacks Investment Research - Vimarsana News

CBTX (NASDAQ:CBTX) Rating Increased to Strong-Buy at Zacks Investment Research

CBTX (NASDAQ:CBTX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday, Zacks.com reports. The firm currently has a $32.00 target price on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 16.32% from the stock’s current […]

Analysts' Updated EPS Estimates for May 24th (ABSI, AIQUY, ALIT, ANPDF, APLT, ATASY, BBAI, BNR, BWB, CBTX) - Vimarsana News

Analysts' Updated EPS Estimates for May 24th (ABSI, AIQUY, ALIT, ANPDF, APLT, ATASY, BBAI, BNR, BWB, CBTX)

Analysts’ updated eps estimates for Tuesday, May 24th: Absci (NASDAQ:ABSI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company’s Creation(TM) Platform involved in discovery […]